US Stock MarketDetailed Quotes

IPA ImmunoPrecise Antibodies

Watchlist
  • 1.220
  • 0.0000.00%
Close Apr 24 16:00 ET
32.10MMarket Cap-2932P/E (TTM)

About ImmunoPrecise Antibodies Company

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.

Company Profile

SymbolIPA
Company NameImmunoPrecise Antibodies
Listing DateDec 30, 2020
Founded1983
CEODr. Jennifer L. Bath
MarketNASDAQ
Employees102
Securities TypeOrdinary Shares
Fiscal Year Ends04-30
Address4464 Markham Street,Suite 3204
CityVictoria
ProvinceBritish Columbia
CountryCanada
Zip CodeV8Z 7X8
Phone1-250-483-0308

Company Executives

  • Name
  • Position
  • Salary
  • Thomas D’Orazio
  • Chief Executive Officer, President and Director
  • --
  • Dr. Jennifer L. Bath
  • Chief Executive Officer, President and Director
  • 2.46M
  • Robert Beecroft
  • Chief Technical Officer and Director
  • --
  • Brad McConn
  • Chief Financial Officer
  • 781.28K
  • Dr. Ilse Roodink
  • Chief Scientific Officer
  • 519.08K
  • Deanna Dryhurst
  • Chief Scientific Officer
  • --
  • Natasha Tsai
  • Chief Financial Officer
  • --
  • Kari Graber
  • Vice President, Commercial Services
  • 516.66K
  • Dr. Barry Duplantis
  • Vice President, Client Relations
  • 620.94K
  • Kevin Wong
  • Vice President of Corporate Services
  • --
  • Mitchell Levine
  • Chairman of the Board
  • --
  • Guy Champagne
  • Director
  • --
  • Chris Buyse
  • Independent Director
  • --
  • Barry A. Springer
  • Independent Director
  • --
  • Dirk Witters
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg